Older adults' and physicians' preferences for respiratory syncytial virus vaccination in Germany and Italy: A discrete choice experiment

医学 接种疫苗 免疫 免疫规划 呼吸道感染 儿科 呼吸系统 免疫学 内科学 抗体
作者
Alen Marijam,Pavo Marijic,Anna Puggina,Olivier Cailloux,Frederik Verelst,Marta Vicentini,Elisa Turriani,Foteini Gkalapi,Indra Jaidhauser,Christina Rieger,Paolo Bonanni,Chiara de Waure,Gernot Rohde,Tommi Tervonen
出处
期刊:Vaccine [Elsevier BV]
卷期号:61: 127390-127390
标识
DOI:10.1016/j.vaccine.2025.127390
摘要

To improve the uptake of respiratory syncytial virus (RSV) vaccination, we used discrete choice experiments (DCEs) to understand the vaccine attributes most important to older adults receiving RSV vaccines and physicians recommending RSV vaccines in Germany and Italy. The vaccine attributes assessed included the level of protection from lower respiratory tract disease provided in the first and second year, flexibility in time of administration, the possibility for co-administration with one other vaccine, and if the vaccine was recommended in clinical guidelines and/or a national immunization program (NIP). DCE results were used to derive relative attribute importance, minimum acceptable benefits, and predicted choice probabilities. A total of 999 older adults and 300 physicians were included. The most important vaccine attributes to both groups were the level of protection provided in the first and second year, and the inclusion of the vaccine in a NIP. Older adults and physicians would only consider a vaccine not included in a NIP if the first-year protection was ≥20-27 % higher than that of a vaccine included in the NIP. Co-administration and time of administration had little to no impact. Older adults aged 60-69 years with chronic conditions associated with increased risks of RSV were most likely to accept RSV vaccination (85 %), vs those aged 50-59 years with these conditions (78 %), aged 60-69 years without these conditions (61 %), or aged ≥70 years (65 %) with/without these conditions. Similarly, German and Italian physicians were most likely to recommend a vaccine to adults aged 60-69 years with chronic conditions as well as to those aged ≥70 years. These results suggest that, to improve RSV vaccine uptake in Germany and Italy, RSV vaccines should remain included in NIPs, and older and physicians should be informed of vaccine protection levels and benefits.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
安吉拉学术记完成签到,获得积分10
5秒前
nnn完成签到,获得积分10
5秒前
5秒前
桐桐的应助被ahe采纳,获得10
6秒前
8秒前
9秒前
10秒前
10秒前
阿白发布了新的文献求助10
10秒前
Zhaoyu完成签到,获得积分10
10秒前
11秒前
漂亮的大神完成签到,获得积分20
11秒前
闪亮的屁灯完成签到 ,获得积分10
12秒前
daisyyy完成签到 ,获得积分10
13秒前
13秒前
一路向北完成签到,获得积分10
14秒前
15秒前
15秒前
ZZZ完成签到 ,获得积分20
16秒前
whatislove发布了新的文献求助20
16秒前
16秒前
科研通AI6.2的应助被675675采纳,获得10
16秒前
余香的应助被青年才俊采纳,获得30
19秒前
wanci的应助被青年才俊采纳,获得10
19秒前
Maestro_S的应助被青年才俊采纳,获得10
19秒前
飘扬雄风发布了新的文献求助10
19秒前
木子完成签到 ,获得积分10
22秒前
汉堡包的应助被WWWJ采纳,获得10
22秒前
依123完成签到 ,获得积分10
24秒前
古古完成签到,获得积分10
24秒前
24秒前
24秒前
24秒前
哆小咪完成签到 ,获得积分10
25秒前
attention完成签到,获得积分10
26秒前
shenjingjing完成签到 ,获得积分10
26秒前
26秒前
小吴完成签到,获得积分10
27秒前
流星雨完成签到,获得积分10
27秒前
元狩完成签到,获得积分10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181767
求助须知:如何正确求助?哪些是违规求助? 9571480
关于积分的说明 21818225
捐赠科研通 7778030
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479598